The company reported robust revenue and profit growth for FY26, supported by strong CDMO performance, improving margins, and expansion across advanced manufacturing platforms
The US FDA completed a pre-license inspection of Biocon Biologics’ biosimilars manufacturing site at Biocon Park between April 20 and April 29, 2026
Fresenius Kabi's approved generic therapy addresses acute symptomatic hypocalcemia and targets a US market valued at nearly $71 million
Pharma major reports FY26 revenue of Rs 9,204 crore with 16.6% growth
The conference brought together over 500 doctors and 150 nutritionists to discuss emerging obesity-related challenges
The Minister emphasised that scientific institutions must actively communicate their achievements and engage with stakeholders
Approval expands Lupin’s specialty portfolio in the US market for treatment of urea cycle disorders
Dr Mohit Bhandari remotely conducted a complex robotic gastrojejunostomy from Perth using the indigenous SSI Mantra Surgical Robotic System
The private funding rose 38% amid growing international collaborations and CDMO demand
The latest addition, a new API facility in Morrisville, North Carolina, will produce key components for solid dosage tablets, capsules, and RNA therapeutics
Subscribe To Our Newsletter & Stay Updated
